
A study by Mahidol University in Thailand found that after transgender men used 3% minoxidil for 12 weeks, the density of upper lip beard and facial hair increased significantly, and the side effects were mostly minor local reactions.
AI-generated summary
Minoxidil was originally an oral medication for high blood pressure and was later developed into a topical hair growth product. Scientists recently conducted a randomized, double-blind trial on its effect on facial hair growth.
British football star David Beckham has a pronounced stubble, showing the growth of hair on a male's face. Research has found that common hair-growing ingredients may increase beard density in certain ethnic groups.
Minoxidil, a common hair growth ingredient, is not only used to improve scalp hair loss. A new study also found that after use by specific groups, the density of beards and upper lip beards increased, and significant differences were observed in the 8th week.
The scientific media "ScienceAlert" reported that this randomized, double-blind, placebo-controlled trial published in the "Journal of Dermatological Treatment" was conducted by a research team at Mahidol University in Thailand. It included 69 transgender men who received stable gender affirmation hormone treatment and were randomly divided into two groups. They applied 3% minoxidil or placebo on their faces every day for 12 weeks.
Researchers observed significant changes in facial hair density in subjects using minoxidil at week 8. By the 12th week, the upper lip beard density in the minoxidil group increased by an average of 18.45 roots/cm2, the beard density increased by 11.16 roots/cm2, and the hair diameter also increased. The side effects that occurred during the trial were mainly local itching, redness and scaling. No serious adverse events were reported.
However, this study focused on transgender men receiving testosterone treatment, and it is unclear whether the results are applicable to men in general or other groups. In addition, topical minoxidil has not been approved by the U.S. Food and Drug Administration (FDA) for facial beard growth. The American Academy of Dermatology also warns that using minoxidil on the face may cause skin irritation, and you should consult a dermatologist before use.
Minoxidil was originally developed as an oral drug to treat high blood pressure. Later, it was developed as a topical hair growth product because of its ability to promote hair growth. Since it also has a vasodilatory effect, if the drug is absorbed through the skin and enters the systemic circulation, it may theoretically cause dizziness, hypotension, rapid heartbeat or palpitations. People should not apply hair growth products on their faces by themselves.

On November 10, World Neuroendocrine Tumor Day, Chongqing University Cancer Hospital held science popularization and charity clinic activities. Experts pointed out that the disease is highly heterogeneous and easily misdiagnosed, and called on the public to improve scientific understanding and achieve early screening, early diagnosis and standardized diagnosis and treatment.

The Centers for Disease Control and Prevention announced that this year the pneumococcal vaccination completion rate for people over 65 years old has increased to 40.9%, and the cumulative number of invasive pneumococcal infection cases has dropped by about 20% compared with the same period last year. Although this year's 40% target has been reached, there are still about 2.9 million people who have not been fully vaccinated. We call on those who are eligible for public funding to get vaccinated as soon as possible.

Chen Baihong, director of the Rehabilitation Department of Kuok General Hospital, pointed out that frozen shoulder (adhesive capsulitis) will not be cured by waiting. Some patients have residual symptoms for more than 10 years. When first-line drugs and rehabilitation are ineffective, ultrasound-guided capsuloplasty can be considered. The procedure takes about 10 minutes and can be completed in an outpatient clinic, but it must be combined with follow-up rehabilitation to completely solve the problem.

The groundbreaking ceremony for the new medical building at the Xindian campus of Catholic Tien Xin Hospital was held on November 10, 2026. New Taipei City Mayor Hou Youyi and New Taipei City mayoral candidates Su Qiaohui and Li Sichuan attended the ceremony. The new building is planned to have 14 floors above ground and 4 floors underground. It will integrate four specialist centers for diabetes, urology, chest and heart, and introduce smart nursing stations, mobile medical services and AI-assisted diagnosis and treatment. The project will cost approximately 6 billion yuan, and the city government will help speed up the administrative process.

The influenza epidemic has cooled down for several consecutive weeks, but the number of severe cases of influenza still exceeded 100 last week. The CDC has not yet announced that it is out of the epidemic period. It will be observed for another two weeks and the conditions for use of antiviral drugs will be extended for the third time to November 30.

A joint German and British study found that changes in glioblastoma cancer cells follow predictable hidden patterns. The research team analyzed the tumor molecular profiles of 12 patients and used the deep learning tool "scDORI" to identify regulatory factors that affect cell state transitions. They also proved that manipulating a few key factors can guide cancer cells to transform into a less aggressive state, but there is still some way to go before clinical application.